Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast CancerN. Lynn Henry, Anna Maria Storniolo, Faouzi Azzouz et al.|Journal of Clinical Oncology|2012Cited by 391
A dual-center randomized controlled double blind trial assessing the effect of acupuncture in reducing musculoskeletal symptoms in breast cancer patients taking aromatase inhibitorsTing Bao, Vered Stearns, Ling Cai et al.|Breast Cancer Research and Treatment|2013Cited by 89
Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancerAditya Bardia, Vered Stearns, Erin T. Arieas et al.|Breast Cancer Research and Treatment|2011Cited by 81
Preclinical and Clinical Evaluation of Intraductally Administered Agents in Early Breast CancerVered Stearns, Saraswati Sukumar, Tsuyoshi Mori et al.|Science Translational Medicine|2011Cited by 77
Patient‐reported outcomes in women with breast cancer enrolled in a dual‐center, double‐blind, randomized controlled trial assessing the effect of acupuncture in reducing aromatase inhibitor‐induced musculoskeletal symptomsTing Bao, Vered Stearns, Ling Cai et al.|Cancer|2013Cited by 64